Italian medical diagnostics group DiaSorin on Tuesday posted a 6% jump in nine-month adjusted core profit to 292 million euros ($318.46 million) at constant exchange rates, driven by its ...

The company reported on Tuesday that its revenues jumped 8 percent in North America and Europe during the third quarter but fell slightly in the rest of the world.

Diasorin SpA (WBO:DIAS) reports robust revenue growth and strategic advancements, despite facing headwinds in China and ...

This new assay is available on the VITROS 3600 Immunodiagnostic System, VITROS 5600, and VITROS XT 7600 Integrated Systems in ...

Equities research analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued on Wednesday. The firm set a “sell” ...

He also researched and developed antigens that could be used to develop immunodiagnostic kits for diagnosing infectious agents. Most recently, Dr. Tumban’s research has been focused on the development ...

He also researched and developed antigens that could be used to develop immunodiagnostic kits for diagnosing infectious agents. Most recently, Dr. Tumban’s research has been focused on the development ...

The base business in this division grew 8%, driven by demand for immunodiagnostic, pathology and molecular solutions products. Roche’s shares have risen 8.2% year to date compared with the ...

They are frequently employed in the context of developing antibodies and vaccines. High-quality antigens and antibodies are also essential elements of immunodiagnostic tests.